1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsCommunity Grants (Pfizer) is sponsored by Pfizer Inc.. Pfizer provides Community Grants to support non-profit organizations and initiatives in communities where Pfizer has facilities and where employees live and work in the U. S.
Get alerted about grants like this
Save a search for “Pfizer Inc.” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Competitive Grants Program | Pfizer Competitive Grants Program Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP.
The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Inflammation & Immunology Support for the Professions British Indian Ocean Territory Congo, The Democratic Republic Falkland Islands (Malvinas) French Southern Territories Heard and Mc Donald Islands Holy See (Vatican City State) Iran (Islamic Republic of) Korea, Democratic People's Rep Lao People's Democratic Republ Macedonia, The Former Yugoslav Micronesia, Federated States o Saint Vincent and the Grenadin Slovakia (Slovak Republic) South Georgia and the South Sa Svalbard and Jan Mayen Islands Tanzania, United Republic of United States Minor Outlying I Wallis and Futuna Islands Efforts to Improve Quality of Migraine Care Release Date: March 4, 2026 Partner: The Japanese Headache Society Review Process: Expert Review Panel View RFP (PDF) Quality Improvement Internal Medicine Japan June 15, 2026 Improving Health Outcomes in Patients with ATTR-CM Through the Development of a Shared Decision-Making Tool (Decision Aid) Release Date: March 10, 2026 Review Process: Pfizer Internal View RFP (PDF) Research Rare Disease USA June 3, 2026 Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma Release Date: March 18, 2026 Review Process: Pfizer Internal View RFP (PDF) Research Oncology Spain May 22, 2026 Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic Diseases Release Date: March 26, 2026 Review Process: Pfizer Internal View RFP (PDF) Education Inflammation & Immunology USA May 21, 2026 B-cell Maturation Antigen (BCMA) Bi-Specific Antibodies (BsAbs) in Relapsed/Refractory Multiple Myeloma (RRMM) Release Date: March 27, 2026 Review Process: Pfizer Internal View RFP (PDF) Education Oncology USA May 18, 2026 Education on Mechanism of Action of JAK3 and TEC Family Kinase Role in Alopecia Areata Release Date: March 30, 2026 Review Process: Pfizer Internal View RFP (PDF) Education Inflammation & Immunology USA May 25, 2026 2026 Hemophilia Fellowship – United States Release Date: April 1, 2026 Review Process: Expert Review Panel View RFP (PDF) Fellowship Rare Disease All May 28, 2026 Pediatric Pneumococcal Disease and Serotype Distribution: Surveillance Studies in Saudi Arabia Release Date: April 1, 2026 Review Process: Pfizer Internal View RFP (PDF) Research Vaccines Saudi Arabia June 1, 2026 Optimising Ulcerative Colitis Care: Bridging Knowledge Gaps, Integrating Biomarker-Based Strategies, and Advancing Equity Release Date: April 2, 2026 Review Process: Expert Review Panel View RFP (PDF) Education Inflammation & Immunology Australia June 1, 2026 Improving Precision Oncology Care Through Molecular Diagnostic Integration and Data Quality Improvement Release Date: April 21, 2026 Review Process: Pfizer Internal View RFP (PDF) Quality Improvement Oncology Kazakhstan June 2, 2026 Inflammation & Immunology Support for the Professions British Indian Ocean Territory Congo, The Democratic Republic Falkland Islands (Malvinas) French Southern Territories Heard and Mc Donald Islands Holy See (Vatican City State) Iran (Islamic Republic of) Korea, Democratic People's Rep Lao People's Democratic Republ Macedonia, The Former Yugoslav Micronesia, Federated States o Saint Vincent and the Grenadin Slovakia (Slovak Republic) South Georgia and the South Sa Svalbard and Jan Mayen Islands Tanzania, United Republic of United States Minor Outlying I Wallis and Futuna Islands Pneumococcal Disease Prevention Release Date: April 11, 2012 Review Process: View RFP (PDF) Release Date: May 8, 2012 Review Process: View RFP (PDF) Release Date: June 28, 2012 Review Process: View RFP (PDF) Pharmacy Pneumococcal Disease Prevention Release Date: June 28, 2012 Review Process: View RFP (PDF) Release Date: July 2, 2012 Review Process: View RFP (PDF) Non-Small Cell Lung Cancer Release Date: July 10, 2012 Review Process: View RFP (PDF) Cardiovascular Risk in Rheumatoid Arthritis Release Date: July 25, 2012 Review Process: View RFP (PDF) Release Date: July 26, 2012 Review Process: View RFP (PDF) Adult Pneumococcal Disease Prevention Release Date: August 29, 2012 Review Process: View RFP (PDF) Prevention of Stroke in Women Release Date: September 13, 2012 Review Process: View RFP (PDF) Oncology Educational Needs Assessments Release Date: October 22, 2012 Review Process: View RFP (PDF) Release Date: November 1, 2012 Review Process: View RFP (PDF)
According to the current listing, eligibility includes: Non-profit organizations and initiatives in communities where Pfizer has facilities and employees in the U. S. Confirm the full requirements in the official notice before applying.
Community Grants (Pfizer) is funded by Pfizer Inc.. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Pfizer Global Medical Grants: Antimicrobial Stewardship and AMR is a competitive grant program from Pfizer Inc. that funds independent initiatives — including research, quality improvement, and education — aimed at improving patient outcomes in antimicrobial stewardship and combating antimicrobial resistance (AMR). Pfizer publishes Requests for Proposals (RFPs) outlining specific gaps in research, practice, or care, and invites organizations to apply. Grantees are responsible for the design, implementation, and conduct of their initiatives. Eligible applicants include medical centers, universities, and healthcare organizations globally. Awards typically range from $50,000 to $250,000. Applications are reviewed on a rolling RFP basis — check Pfizer's grants portal for current open solicitations.
Competitive Grants Program (General RFP for independent initiatives) is a grant from Pfizer Inc. that funds arts projects and programming. Project Types and Area of Interest Potential applicants are encouraged to identify and address educational gaps relating to optimal application and management of targeted therapies for patients with mPC in diverse clinical practice settings. Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an independent group of physicians not affiliated with a hospital, academic institution, or professional society). Eligible applicants include medical, scientific, patient, and civic organizations; healthcare institutions; professional associations; medical societies; medical education companies; and other healthcare-related entities.